Quoin Pharmaceuticals, Ltd. (QNRX)

Quoin Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3.82	3.62	2.4	2.86	7.48	0.32
Short-Term Investments	7.73	10.43	8.29	9.99	-	-
Cash & Short-Term Investments	11.55	14.06	10.69	12.85	7.48	0.32
Cash Growth	-21.36%	31.44%	-16.79%	71.78%	2210.70%	-
Prepaid Expenses	0.94	0.87	0.59	0.52	0.72	-
Other Current Assets	-	-	-	-	-	0.14
Total Current Assets	12.5	14.93	11.29	13.37	8.2	0.47
Other Intangible Assets	0.46	0.48	0.58	0.7	0.81	0.91
Other Long-Term Assets	-	0.3	0.3	0.38	0.35	-
Total Assets	12.96	15.71	12.17	14.46	9.36	1.38
Accounts Payable	0.64	0.91	0.53	0.61	0.92	-
Accrued Expenses	3.61	2.68	2.45	2.32	2.43	4.99
Short-Term Debt	-	-	-	-	-	1.21
Current Portion of Long-Term Debt	0.6	0.6	0.6	0.6	0.6	-
Other Current Liabilities	-	-	-	-	0.62	1.78
Total Current Liabilities	4.86	4.18	3.58	3.53	4.58	7.99
Long-Term Debt	2.17	2.32	2.92	3.52	4.12	-
Total Liabilities	7.03	6.5	6.51	7.05	8.7	7.99
Additional Paid-In Capital	64.9	64.37	51.87	47.86	31.66	0
Retained Earnings	-58.98	-55.17	-46.2	-37.52	-28.07	-6.61
Treasury Stock	-	-	-	-2.93	-2.93	-
Shareholders' Equity	5.93	9.2	5.66	7.41	0.66	-6.61
Total Liabilities & Equity	12.96	15.71	12.17	14.46	9.36	1.38
Total Debt	2.77	2.92	3.52	4.12	4.72	1.21
Net Cash (Debt)	8.78	11.13	7.17	8.73	2.76	-0.89
Net Cash Growth	-22.42%	55.25%	-17.85%	216.41%	-	-
Net Cash Per Share	-	83.11	278.59	-	-	-
Filing Date Shares Outstanding	-	0.59	0.11	0.03	-	0.03
Total Common Shares Outstanding	-	0.26	0.03	0.01	-	0.03
Working Capital	7.64	10.75	7.7	9.84	3.62	-7.52
Book Value Per Share	-	36.00	200.81	641.72	-	-231.26
Tangible Book Value	5.47	8.72	5.08	6.7	-0.15	-7.52
Tangible Book Value Per Share	-	34.11	180.13	580.68	-	-263.20

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q